All Versions

Contents

Index

Standard

HL7 - Version 2.7

2.1

2.2

2.3

2.3.1

2.4

2.5

2.6

2.7

2.8

2.9

2.9.1

2.7

2.7 DE

2.7.1

Events

Segments

Msg. Types

Msg. Structs

Data Elements

Tables

Data Structs

Queries

Segment OBX: Observation/Result (Ergebnis/Befund)

Seq	Description	German Interpretation	Length	C.LEN	Table	r/o/c	Rep#	Item	Data Structure	Section
1	Set ID - OBX	OBX-Segmentnummer	1..4			O		00569	SI	7.4.2.1
2	Value Type	Ergebnisformat (Datentyp von Feld OBX-5)	2..3		0125	C		00570	ID	7.4.2.2
3	Observation Identifier	Bezeichnung der Untersuchung			9999	R		00571	CWE	7.4.2.3
4	Observation Sub-ID	Differenzierung von Ergebnissen einer Untersuchung		20=		C		00572	ST	7.4.2.4
5	Observation Value	(Teil-) Ergebnis / Meßwert				C	Y	00573	varies	7.4.2.5
6	Units	Maßeinheit			9999	O		00574	CWE	7.4.2.6
7	References Range	Referenzbereich / Normalbereich		60=		O		00575	ST	7.4.2.7
8	Interpretation Codes	Bewertung des Ergebnisses / Meßwerts				O	Y	00576	CWE	7.4.2.8
9	Probability	Wahrscheinlichkeit / Zuverlässigkeit des Ergebnisses bzw. Meßwerts		5#		O		00577	NM	7.4.2.9
10	Nature of Abnormal Test	Art des Referenzbereiches	1..2		0080	O	Y	00578	ID	7.4.2.10
11	Observation Result Status	Ergebnisstatus	1..1		0085	R		00579	ID	7.4.2.11
12	Effective Date of Reference Range	Datum der letzten Referenzbereichsfestlegung im System				O		00580	DTM	7.4.2.12
13	User Defined Access Checks	benutzerdefinierte Zugriffsberechtigung (für dieses Ergebnis)		20=		O		00581	ST	7.4.2.13
14	Date/Time of the Observation	Zeitpunkt der Untersuchung / Probenentnahme				O		00582	DTM	7.4.2.14
15	Producer's ID	Kennzeichen der Untersuchungsstelle			9999	B		00583	CWE	7.4.2.15
16	Responsible Observer	Verantwortlicher Untersucher				B	Y	00584	XCN	7.4.2.16
17	Observation Method	Untersuchungsmethode			9999	O	Y	00936	CWE	7.4.2.17
18	Equipment Instance Identifier	ID des Gerätes				B	Y	01479	EI	7.4.2.18
19	Date/Time of the Analysis	Zeitpunkt der Analyse				O		01480	DTM	7.4.2.19
20	Observation Site	Beobachtungsort/Messpunkt			0163	O	Y	02179	CWE	7.4.2.20
21	Observation Instance Identifier	ID der Beobachtung				O		02180	EI	7.4.2.21
22	Mood Code	Mood-Code			0725	C		02182	CNE	7.4.2.22
23	Performing Organization Name	Ausführende Organisation - Name				B	N	02283	XON	7.4.2.23
24	Performing Organization Address	Ausführende Organisation - Adresse				B	N	02284	XAD	7.4.2.24
25	Performing Organization Medical Director	Ausführende Organisation - med. Leitung				B	N	02285	XCN	7.4.2.25
26	Patient Results Release Category		1..10		0909	O	N	02313	ID	7.4.2.26

Used within following Message Structures:

ADT_A01 ADT Admission Message (3.3.1)

ADT_A02 ADT Transfer Message (3.3.2)

ADT_A03 ADT Discharge Message (3.3.3)

ADT_A05 ADT Message (3.3.5)

ADT_A06 ADT Message (3.3.6)

ADT_A09 Track/Cancel (3.3.9)

ADT_A12 Track/Cancel (2) (3.3.12)

ADT_A15 ADT Message (3.3.15)

ADT_A16 Pending Discharge (3.3.16)

ADT_A17 Swap (3.3.17)

ADT_A21 ADT Message (3.3.21)

ADT_A38 Swap (2) (3.3.38)

BAR_P01 Add Billing Account (6.4.1)

BAR_P05 Update Billing Account (6.4.5)

BAR_P12 Update Diagnosis/Procedure (6.4.9)

CCI_I22 Collaborative Care Information (11.7.2)

CCM_I21 Collaborative Care Message (11.6.1)

CCR_I16 Collaborative Care Referral (11.6.2)

CCU_I20 Collaborative Care Referral (11.6.6)

CQU_I19 Collaborative Care Referral (11.7.1)

CSU_C09 Clinical Trial Message (7.7.2)

DFT_P03 Detail Financial Transaction (6.4.3)

DFT_P11 Detail Financial Transaction - Expanded (6.4.8)

EHC_E01 Submit HealthCare Services Invoice (16.3.1)

EHC_E12 Request Additional Information (16.3.7)

EHC_E13 Additional Information Response (16.3.8)

EHC_E20 Submit Authorization Request (16.3.10)

MDM_T02 Document Replacement Notification & Content (9.6.2)

OMB_O27 Blood Product Order Message (4.13.1)

OMD_O03 Dietary Order (4.7.1)

OMG_O19 General Clinical Order Message (4.4.4)

OMI_O23 Imaging Order Message (4.4.14)

OML_O21 Laboratory Order Message (4.4.6)

OML_O33 Laboratory Order - Multiple Order Per Specimen Mes (4.4.8)

OML_O35 Laboratory Order - Multiple Order Per Container of (4.4.10)

OML_O39 Specimen Shipment Centric Laboratory Order Message (4.4.12)

OMN_O07 Nonstock Requisition Order Message (4.10.3)

OMP_O09 Pharmacy/treatment Order Message (4.A.3.2)

OMS_O05 Stock Requisition Order Message (4.10.1)

OPL_O37 Population/Location-Based Laboratory Order Message (4.4.16)

OPR_O38 Population/Location-Based Laboratory Order Acknowl (4.4.17)

OPU_R25 Observation Message (7.3.11)

ORL_O34 Laboratory Order Acknowledgment Message - Multipl (4.4.9)

ORL_O36 Laboratory Order Acknowledgment Message - Multipl (4.4.11)

ORU_R01 Observation Message (7.3.1)

ORU_R30 Observation Message (7.3.4)

OSM_R26 Specimen Shipment Message (7.18.1)

OUL_R22 Observation Message (7.3.8)

OUL_R23 Observation Message (7.3.9)

OUL_R24 Observation Message (7.3.10)

PEX_P07 Product Experience Message (7.11.1)

PGL_PC6 Patient Goal Message (12.3.1)

PPG_PCG Patient Pathway Goal-Oriented Message (12.3.4)

PPP_PCB Patient Pathway Problem-Oriented Message (12.3.3)

PPR_PC1 Patient Problem Message (12.3.2)

PPT_PCL Patient Pathway Goal-Oriented Response (12.3.12)

PPV_PCA Goal Query Response (12.3.8)

PRR_PC5 Problem Query Response (12.3.6)

PTR_PCF Patient Pathway Problem-Oriented Response (12.3.10)

RAS_O17 Pharmacy/Treatment Administration (4.A.3.10)

RCI_I05 Return Clinical Information (11.3.5)

RDE_O11 Pharmacy/Treatment Refill Authorization Request (4.A.3.4)

RDS_O13 Pharmacy/Treatment Dispense Message (4.A.3.6)

REF_I12 Patient Referral (11.5.1)

RGV_O15 Pharmacy/Treatment Give (4.A.3.8)

RPA_I08 Return Patient Authorization (11.4.1)

RQA_I08 Request Patient Authorization (11.4.1)

RRI_I12 Return Referral Information (11.5.1)

RSP_K31 Response Grammar: Pharmacy Dispense Message (4.A.3.19)

RSP_Z82 Response Grammar: Pharmacy Dispense Message (5.9.1.0.1)

RSP_Z86 Response Grammar: Pharmacy Information Comprehens (5.9.1.1.1)

RSP_Z88 Response Grammar: Pharmacy Information Comprehens (5.9.2.0.1)

RSP_Z90 Response Grammar: Pharmacy Information Comprehens (5.9.2.3)

SIU_S12 Schedule Information Unsolicited (10.4)

SRM_S01 Schedule Request Message (10.3)

SSU_U03 Specimen Status Message (13.3.3)

VXU_V04 Unsolicited Vaccination Update (4.A.7.5)

Links to Other/Further HL7 Information

generated: Aug 07, 2023 (FO)

Health Level Seven, Int. (HQ)

HL7 Germany
HL7 Europe

Frank Oemig's HL7 Site
(Infos about the database)

HL7-Experts Network